The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption
Ive done quite a bit of research and this is the fastest and easiest way to get B12 injections in the states
By administering BPC-157 in oral capsule form, subjects of research studies can easily incorporate this regenerative peptide into their daily routine without the need for injections which can cause discomfort
Some patients report a pale or yellowish tinge to the skin, and glossitis (a sore, red tongue) may develop
The full investigation by Sara Talpos, is available at statnews.com
Zoellner JM, Hedrick VE, You W, et al